Statistics for BioLife Solutions (id:5292 BLFS)

Valuation metrics

Market cap

1.21B

Enterprise value

1.18B

Trailing P/E (ttm)

-17.11

Forward P/E

-92.89

PEG ratio

-92.89

Price/Sales (ttm)

8.21

Price/Book (mrq)

3.69

Enterprise Value/Revenue

8.05

Enterprise Value/EBITDA

-42.24

Overview

Shares outstanding

46.39M

Float

36.10M

Shares short

3.50M

% Held by insiders

0.02%

% Held by institutions

0.99%

Average volume (10 days)

835.44K

Average volume (90 days)

Price summary

52-Week low

11.91

52-Week high

28.88

52-Week change

45.87%

Beta

1.88

50-Day moving average

23.98

200-Day moving average

21.29

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

January 29th, 2014

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-31.32%

Operating margin

-5.10%

Operational effectiveness

Return on assets

-5.97%

Return on equity

-15.04%

Income statement

Revenue (ttm)

3.22

Revenue per share (ttm)

3.22

Quarterly revenue growth (yoy)

Gross profit (ttm)

46.75M

EBITDA

-28,005,000.00

Net income to common (ttm)

-49,445,000.00

Diluted EPS (ttm)

-1.11

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

34.19M

Total cash per share (mrq)

0.74

Total debt (mrq)

39.27M

Total Debt/Equity (mrq)

12.06

Current ratio (mrq)

277.90%

Book value per share (mrq)

7.04

Cash flow

Cash flow statement

9.10M

Levered free cash flow (LFCF)

10.14M